DIA
LOXO

Denver Investment Advisors’s Loxo Oncology, Inc LOXO Stock Holding History

Denver Investment Advisors’s Portfolio LOXO Stock Details LOXO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		$442K Sell
3,834
-858
-18% -$91.3K 0.02% 334
2017
Q4 		$395K Buy
+4,692
New +$391K 0.02% 345

Other funds holding LOXO

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
AC
Aisling Capital New York $45.3M AUM 15.24% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
O
OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

Denver Investment Advisors's LOXO Position: Q1 2018 in Review

Denver Investment Advisors reduced its Loxo Oncology, Inc (LOXO) stake by 18% in Q1 2018, selling an estimated $91.3K and leaving 3,834 shares worth $442K. The position accounts for 0.02% of the portfolio, ranked #334.

Denver Investment Advisors first reported a position in LOXO in Q4 2017 and has held it in 2 quarters since. 158 funds tracked by Wall St. Rank hold LOXO as of Q1 2018.

  • Denver Investment Advisors held 3,834 shares of Loxo Oncology, Inc worth $442K as of Q1 2018.
  • Denver Investment Advisors sold 858 Loxo Oncology, Inc shares in Q1 2018, an estimated $91.3K.
  • Loxo Oncology, Inc made up 0.02% of Denver Investment Advisors's portfolio in Q1 2018, its #334 holding.
  • Denver Investment Advisors first reported a position in Loxo Oncology, Inc in Q4 2017 and has held it in 2 quarters since.
  • 158 funds tracked by Wall St. Rank held Loxo Oncology, Inc as of Q1 2018.

Based on Denver Investment Advisors's 13F filing for Q1 2018, filed 10 May 2018.